Share Price and Basic Stock Data
Last Updated: December 13, 2025, 8:19 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Kothari Sugars & Chemicals Ltd operates within the sugar industry, a sector often marred by volatility due to fluctuating sugar prices and changing government policies. As of the latest reports, the company’s market capitalization stood at ₹222 Cr, with the stock price at ₹26.7. Over the past few quarters, Kothari has exhibited a mixed revenue performance. For instance, sales peaked at ₹609 Cr in FY 2023 but saw a decline to ₹503 Cr in FY 2024, reflecting a challenging environment. Recent quarterly figures, such as ₹162.96 Cr in June 2023, followed by ₹113.18 Cr in September 2023, highlight the inconsistencies in revenue generation. The company’s operational dynamics are further complicated by its cash conversion cycle of 71 days, which indicates moderate efficiency in managing working capital. The combination of fluctuating sales and extended cash cycles presents a challenging landscape for long-term growth.
Profitability and Efficiency Metrics
When analyzing Kothari Sugars’ profitability, the numbers reveal a rather concerning narrative. The operating profit margin (OPM) has been inconsistent, recorded at a mere 1.63% at present, down from more favorable margins in previous years. For instance, in FY 2023, the OPM stood at 10%, but this has since declined, reflecting rising costs and operational challenges. In the quarterly results, the company reported a net profit of just ₹12 Cr, translating to a return on equity (ROE) of only 1.69%. This suggests that the company is not effectively utilizing its equity base to generate profit. Additionally, the interest coverage ratio of 5.08x is a positive aspect, indicating that Kothari can comfortably meet its interest obligations. However, the declining net profit margins and low operational efficiency raise questions about sustainability in its current operational model.
Balance Sheet Strength and Financial Ratios
Kothari’s balance sheet presents a mixed picture of financial health. The company holds ₹200 Cr in reserves, which provides a cushion against the volatility of the sugar market. However, it also carries ₹49 Cr in borrowings, which while manageable, indicates that the company is not entirely debt-free. The price-to-book value (P/BV) ratio stands at a mere 0.11x, suggesting that the market may undervalue the company relative to its book value. This could indicate potential for growth, but it also reflects investor skepticism regarding future profitability. The current ratio appears comfortable at 1.07, suggesting that Kothari can meet short-term liabilities. However, the negative trends in profitability metrics and a cash conversion cycle of 71 days suggest that while the balance sheet is stable, operational efficiency needs significant improvement to enhance overall financial viability.
Shareholding Pattern and Investor Confidence
The shareholding structure of Kothari Sugars reveals a significant concentration of ownership, with promoters holding 73.53% of the equity. This high promoter stake can be a double-edged sword; it reflects confidence from the company’s founders but may also limit the influence of public and institutional investors. Notably, foreign institutional investors (FIIs) hold just 0.22%, while domestic institutional investors (DIIs) account for 0.63%. This low institutional interest might reflect concerns over the company’s profitability and growth prospects. However, the public shareholding stands at 25.61%, indicating a reasonable level of retail investor engagement. With 68,598 shareholders, the company does have a base of support, but the lack of institutional backing could be a red flag for potential investors looking for stability and robust governance.
Outlook, Risks, and Final Insight
Looking ahead, Kothari Sugars faces a mixed bag of opportunities and risks. The sugar industry is inherently cyclical, meaning that price fluctuations can significantly impact profitability. If global sugar prices rebound, Kothari could benefit, but the current operational inefficiencies present a significant risk. Rising costs and a declining trend in profit margins could further squeeze the bottom line, making it essential for management to focus on enhancing operational efficiencies and cost control. Additionally, the concentrated shareholding structure may deter new institutional investments, which could limit the company’s ability to raise capital for future growth initiatives. Investors should weigh these factors carefully, considering both the potential upside if the company can turn around its profitability and the risks inherent in its current operational model.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 79.6 Cr. | 10.7 | 16.7/7.02 | 284 | 16.8 | 0.00 % | 36.6 % | % | 10.0 |
| Dhampure Speciality Sugars Ltd | 81.6 Cr. | 93.4 | 136/82.0 | 20.7 | 45.3 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 530 Cr. | 79.9 | 126/57.3 | 310 | 145 | 1.56 % | 3.97 % | 1.56 % | 10.0 |
| DCM Shriram Industries Ltd | 1,428 Cr. | 164 | 211/142 | 23.4 | 105 | 1.22 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 545 Cr. | 3.81 | 12.4/3.03 | 43.1 | 3.52 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
| Industry Average | 1,762.37 Cr | 263.53 | 44.93 | 225.56 | 0.68% | 8.62% | 7.89% | 6.37 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 157.41 | 116.81 | 128.28 | 207.48 | 162.96 | 113.18 | 132.31 | 94.28 | 89.62 | 101.59 | 82.75 | 36.05 | 66.69 |
| Expenses | 119.78 | 114.49 | 136.43 | 178.65 | 133.19 | 101.47 | 132.58 | 91.17 | 88.54 | 90.95 | 79.35 | 38.91 | 65.60 |
| Operating Profit | 37.63 | 2.32 | -8.15 | 28.83 | 29.77 | 11.71 | -0.27 | 3.11 | 1.08 | 10.64 | 3.40 | -2.86 | 1.09 |
| OPM % | 23.91% | 1.99% | -6.35% | 13.90% | 18.27% | 10.35% | -0.20% | 3.30% | 1.21% | 10.47% | 4.11% | -7.93% | 1.63% |
| Other Income | 0.28 | 4.18 | 2.09 | 5.61 | 2.53 | 3.61 | 4.02 | 5.24 | 3.96 | 3.56 | 9.15 | 6.07 | 5.84 |
| Interest | 1.56 | 1.31 | 0.69 | 0.34 | 1.46 | 1.06 | 0.23 | 0.79 | 2.20 | 0.82 | 0.00 | 0.56 | 1.67 |
| Depreciation | 3.52 | 3.47 | 3.50 | 3.55 | 3.34 | 3.63 | 3.54 | 3.77 | 3.66 | 3.66 | 3.67 | 3.66 | 3.62 |
| Profit before tax | 32.83 | 1.72 | -10.25 | 30.55 | 27.50 | 10.63 | -0.02 | 3.79 | -0.82 | 9.72 | 8.88 | -1.01 | 1.64 |
| Tax % | 30.37% | -55.23% | -28.49% | 22.39% | 34.87% | 51.27% | -3,850.00% | -48.81% | -35.37% | 35.70% | 39.19% | -31.68% | 23.78% |
| Net Profit | 22.87 | 2.67 | -7.33 | 23.71 | 17.90 | 5.18 | 0.76 | 5.65 | -0.53 | 6.25 | 5.40 | -0.69 | 1.25 |
| EPS in Rs | 2.76 | 0.32 | -0.88 | 2.86 | 2.16 | 0.62 | 0.09 | 0.68 | -0.06 | 0.75 | 0.65 | -0.08 | 0.15 |
Last Updated: August 20, 2025, 8:00 am
Below is a detailed analysis of the quarterly data for Kothari Sugars & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 66.69 Cr.. The value appears strong and on an upward trend. It has increased from 36.05 Cr. (Mar 2025) to 66.69 Cr., marking an increase of 30.64 Cr..
- For Expenses, as of Jun 2025, the value is 65.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 38.91 Cr. (Mar 2025) to 65.60 Cr., marking an increase of 26.69 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.09 Cr.. The value appears strong and on an upward trend. It has increased from -2.86 Cr. (Mar 2025) to 1.09 Cr., marking an increase of 3.95 Cr..
- For OPM %, as of Jun 2025, the value is 1.63%. The value appears strong and on an upward trend. It has increased from -7.93% (Mar 2025) to 1.63%, marking an increase of 9.56%.
- For Other Income, as of Jun 2025, the value is 5.84 Cr.. The value appears to be declining and may need further review. It has decreased from 6.07 Cr. (Mar 2025) to 5.84 Cr., marking a decrease of 0.23 Cr..
- For Interest, as of Jun 2025, the value is 1.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.56 Cr. (Mar 2025) to 1.67 Cr., marking an increase of 1.11 Cr..
- For Depreciation, as of Jun 2025, the value is 3.62 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.66 Cr. (Mar 2025) to 3.62 Cr., marking a decrease of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.64 Cr.. The value appears strong and on an upward trend. It has increased from -1.01 Cr. (Mar 2025) to 1.64 Cr., marking an increase of 2.65 Cr..
- For Tax %, as of Jun 2025, the value is 23.78%. The value appears to be increasing, which may not be favorable. It has increased from -31.68% (Mar 2025) to 23.78%, marking an increase of 55.46%.
- For Net Profit, as of Jun 2025, the value is 1.25 Cr.. The value appears strong and on an upward trend. It has increased from -0.69 Cr. (Mar 2025) to 1.25 Cr., marking an increase of 1.94 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.15. The value appears strong and on an upward trend. It has increased from -0.08 (Mar 2025) to 0.15, marking an increase of 0.23.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:58 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 323 | 340 | 247 | 317 | 287 | 332 | 352 | 419 | 422 | 609 | 503 | 310 | 287 |
| Expenses | 302 | 331 | 229 | 280 | 259 | 309 | 324 | 386 | 373 | 548 | 458 | 298 | 275 |
| Operating Profit | 21 | 9 | 18 | 36 | 28 | 23 | 28 | 33 | 50 | 61 | 44 | 12 | 12 |
| OPM % | 7% | 3% | 7% | 11% | 10% | 7% | 8% | 8% | 12% | 10% | 9% | 4% | 4% |
| Other Income | 9 | 11 | 7 | -1 | -5 | 20 | 11 | 10 | 8 | 12 | 15 | 23 | 25 |
| Interest | 10 | 5 | 7 | 8 | 6 | 7 | 7 | 5 | 4 | 4 | 4 | 4 | 3 |
| Depreciation | 16 | 16 | 15 | 15 | 14 | 13 | 13 | 14 | 14 | 14 | 14 | 15 | 15 |
| Profit before tax | 5 | -0 | 3 | 13 | 3 | 23 | 19 | 23 | 39 | 55 | 42 | 17 | 19 |
| Tax % | 39% | 1,200% | 58% | 17% | 82% | 44% | -2% | 19% | 14% | 24% | 30% | 38% | |
| Net Profit | 3 | -5 | 1 | 10 | 0 | 13 | 19 | 19 | 34 | 42 | 29 | 10 | 12 |
| EPS in Rs | 0.34 | -0.55 | 0.14 | 1.26 | 0.06 | 1.53 | 2.34 | 2.29 | 4.11 | 5.06 | 3.56 | 1.26 | 1.47 |
| Dividend Payout % | 149% | 0% | 0% | 40% | 0% | 33% | 0% | 0% | 0% | 20% | 14% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -266.67% | 120.00% | 900.00% | -100.00% | 46.15% | 0.00% | 78.95% | 23.53% | -30.95% | -65.52% |
| Change in YoY Net Profit Growth (%) | 0.00% | 386.67% | 780.00% | -1000.00% | 146.15% | -46.15% | 78.95% | -55.42% | -54.48% | -34.56% |
Kothari Sugars & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -3% |
| 3 Years: | -10% |
| TTM: | -33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -20% |
| 3 Years: | -47% |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | -10% |
| 1 Year: | -43% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 9:20 am
Balance Sheet
Last Updated: December 4, 2025, 1:32 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 |
| Reserves | 38 | 34 | 35 | 49 | 56 | 69 | 84 | 103 | 137 | 175 | 196 | 206 | 200 |
| Borrowings | 144 | 166 | 175 | 146 | 120 | 116 | 84 | 36 | 57 | 38 | 70 | 50 | 49 |
| Other Liabilities | 110 | 75 | 76 | 103 | 110 | 123 | 124 | 119 | 118 | 137 | 135 | 111 | 87 |
| Total Liabilities | 375 | 358 | 368 | 380 | 370 | 391 | 375 | 341 | 395 | 433 | 483 | 451 | 419 |
| Fixed Assets | 219 | 209 | 195 | 191 | 178 | 167 | 172 | 162 | 153 | 152 | 164 | 150 | 150 |
| CWIP | 6 | 0 | 0 | 0 | -0 | 1 | -0 | 0 | 1 | 9 | 0 | 4 | 10 |
| Investments | 16 | 18 | 18 | 20 | 33 | 48 | 30 | 58 | 71 | 72 | 100 | 133 | 116 |
| Other Assets | 135 | 131 | 155 | 169 | 159 | 174 | 172 | 121 | 170 | 200 | 219 | 162 | 143 |
| Total Assets | 375 | 358 | 368 | 380 | 370 | 391 | 375 | 341 | 395 | 433 | 483 | 451 | 419 |
Below is a detailed analysis of the balance sheet data for Kothari Sugars & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 83.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 83.00 Cr..
- For Reserves, as of Sep 2025, the value is 200.00 Cr.. The value appears to be declining and may need further review. It has decreased from 206.00 Cr. (Mar 2025) to 200.00 Cr., marking a decrease of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 49.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 50.00 Cr. (Mar 2025) to 49.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 87.00 Cr.. The value appears to be improving (decreasing). It has decreased from 111.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 24.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 419.00 Cr.. The value appears to be improving (decreasing). It has decreased from 451.00 Cr. (Mar 2025) to 419.00 Cr., marking a decrease of 32.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 150.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 150.00 Cr..
- For CWIP, as of Sep 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 6.00 Cr..
- For Investments, as of Sep 2025, the value is 116.00 Cr.. The value appears to be declining and may need further review. It has decreased from 133.00 Cr. (Mar 2025) to 116.00 Cr., marking a decrease of 17.00 Cr..
- For Other Assets, as of Sep 2025, the value is 143.00 Cr.. The value appears to be declining and may need further review. It has decreased from 162.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 19.00 Cr..
- For Total Assets, as of Sep 2025, the value is 419.00 Cr.. The value appears to be declining and may need further review. It has decreased from 451.00 Cr. (Mar 2025) to 419.00 Cr., marking a decrease of 32.00 Cr..
Notably, the Reserves (200.00 Cr.) exceed the Borrowings (49.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -123.00 | -157.00 | -157.00 | -110.00 | -92.00 | -93.00 | -56.00 | -3.00 | -7.00 | 23.00 | -26.00 | -38.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 15 | 9 | 14 | 16 | 23 | 19 | 28 | 18 | 21 | 17 | 16 | 20 |
| Inventory Days | 152 | 139 | 236 | 235 | 224 | 216 | 181 | 101 | 165 | 117 | 180 | 161 |
| Days Payable | 72 | 45 | 60 | 88 | 133 | 127 | 111 | 95 | 99 | 73 | 93 | 110 |
| Cash Conversion Cycle | 95 | 103 | 189 | 162 | 114 | 108 | 99 | 24 | 88 | 61 | 103 | 71 |
| Working Capital Days | 30 | 20 | 8 | 0 | -17 | -10 | -1 | 2 | 16 | 24 | 30 | 36 |
| ROCE % | 5% | 1% | 3% | 9% | 7% | 10% | 8% | 10% | 17% | 18% | 14% | 3% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.28 | 1.44 | 0.37 | -0.26 | 0.43 |
| Diluted EPS (Rs.) | 0.28 | 1.44 | 0.37 | -0.26 | 0.43 |
| Cash EPS (Rs.) | 1.71 | 3.06 | 1.91 | 1.39 | 2.18 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 16.85 | 17.41 | 15.66 | 15.52 | 16.06 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 16.85 | 17.41 | 15.66 | 15.52 | 16.06 |
| Revenue From Operations / Share (Rs.) | 34.62 | 38.21 | 29.75 | 41.02 | 39.02 |
| PBDIT / Share (Rs.) | 3.98 | 5.05 | 2.97 | 2.52 | 3.64 |
| PBIT / Share (Rs.) | 2.31 | 3.29 | 1.20 | 0.59 | 1.70 |
| PBT / Share (Rs.) | 0.30 | 1.56 | 0.34 | -0.02 | 0.49 |
| Net Profit / Share (Rs.) | 0.04 | 1.30 | 0.13 | -0.53 | 0.23 |
| NP After MI And SOA / Share (Rs.) | 0.27 | 1.44 | 0.36 | -0.26 | 0.43 |
| PBDIT Margin (%) | 11.50 | 13.22 | 9.97 | 6.14 | 9.32 |
| PBIT Margin (%) | 6.67 | 8.60 | 4.03 | 1.44 | 4.35 |
| PBT Margin (%) | 0.86 | 4.08 | 1.16 | -0.05 | 1.27 |
| Net Profit Margin (%) | 0.11 | 3.39 | 0.46 | -1.31 | 0.61 |
| NP After MI And SOA Margin (%) | 0.79 | 3.77 | 1.23 | -0.63 | 1.11 |
| Return on Networth / Equity (%) | 1.64 | 8.28 | 2.33 | -1.68 | 2.70 |
| Return on Capital Employeed (%) | 9.11 | 11.54 | 3.90 | 1.80 | 4.85 |
| Return On Assets (%) | 0.60 | 2.98 | 0.79 | -0.58 | 0.92 |
| Long Term Debt / Equity (X) | 0.25 | 0.37 | 0.71 | 0.83 | 0.86 |
| Total Debt / Equity (X) | 0.73 | 0.78 | 1.06 | 1.16 | 0.89 |
| Asset Turnover Ratio (%) | 0.73 | 0.82 | 0.66 | 0.91 | 0.83 |
| Current Ratio (X) | 1.07 | 1.14 | 1.33 | 1.46 | 1.46 |
| Quick Ratio (X) | 0.29 | 0.26 | 0.40 | 0.45 | 0.40 |
| Inventory Turnover Ratio (X) | 1.47 | 1.92 | 1.83 | 2.58 | 2.51 |
| Dividend Payout Ratio (NP) (%) | 217.73 | 0.00 | 0.00 | 0.00 | 115.05 |
| Dividend Payout Ratio (CP) (%) | 30.89 | 0.00 | 0.00 | 0.00 | 21.03 |
| Earning Retention Ratio (%) | -117.73 | 0.00 | 0.00 | 0.00 | -15.05 |
| Cash Earning Retention Ratio (%) | 69.11 | 0.00 | 0.00 | 0.00 | 78.97 |
| Interest Coverage Ratio (X) | 5.08 | 5.16 | 3.47 | 4.11 | 3.03 |
| Interest Coverage Ratio (Post Tax) (X) | 2.62 | 3.09 | 1.16 | 0.12 | 1.20 |
| Enterprise Value (Cr.) | 116.17 | 126.76 | 138.08 | 160.99 | 139.15 |
| EV / Net Operating Revenue (X) | 0.40 | 0.40 | 0.55 | 0.47 | 0.43 |
| EV / EBITDA (X) | 3.52 | 3.03 | 5.61 | 7.71 | 4.61 |
| MarketCap / Net Operating Revenue (X) | 0.05 | 0.05 | 0.06 | 0.04 | 0.05 |
| Retention Ratios (%) | -117.73 | 0.00 | 0.00 | 0.00 | -15.05 |
| Price / BV (X) | 0.11 | 0.11 | 0.12 | 0.12 | 0.12 |
| Price / Net Operating Revenue (X) | 0.05 | 0.05 | 0.06 | 0.04 | 0.05 |
| EarningsYield | 0.13 | 0.72 | 0.18 | -0.13 | 0.21 |
After reviewing the key financial ratios for Kothari Sugars & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 18, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 1.44 (Mar 17) to 0.28, marking a decrease of 1.16.
- For Diluted EPS (Rs.), as of Mar 18, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 1.44 (Mar 17) to 0.28, marking a decrease of 1.16.
- For Cash EPS (Rs.), as of Mar 18, the value is 1.71. This value is below the healthy minimum of 3. It has decreased from 3.06 (Mar 17) to 1.71, marking a decrease of 1.35.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.85. It has decreased from 17.41 (Mar 17) to 16.85, marking a decrease of 0.56.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.85. It has decreased from 17.41 (Mar 17) to 16.85, marking a decrease of 0.56.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 34.62. It has decreased from 38.21 (Mar 17) to 34.62, marking a decrease of 3.59.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 3.98. This value is within the healthy range. It has decreased from 5.05 (Mar 17) to 3.98, marking a decrease of 1.07.
- For PBIT / Share (Rs.), as of Mar 18, the value is 2.31. This value is within the healthy range. It has decreased from 3.29 (Mar 17) to 2.31, marking a decrease of 0.98.
- For PBT / Share (Rs.), as of Mar 18, the value is 0.30. This value is within the healthy range. It has decreased from 1.56 (Mar 17) to 0.30, marking a decrease of 1.26.
- For Net Profit / Share (Rs.), as of Mar 18, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 1.30 (Mar 17) to 0.04, marking a decrease of 1.26.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is 0.27. This value is below the healthy minimum of 2. It has decreased from 1.44 (Mar 17) to 0.27, marking a decrease of 1.17.
- For PBDIT Margin (%), as of Mar 18, the value is 11.50. This value is within the healthy range. It has decreased from 13.22 (Mar 17) to 11.50, marking a decrease of 1.72.
- For PBIT Margin (%), as of Mar 18, the value is 6.67. This value is below the healthy minimum of 10. It has decreased from 8.60 (Mar 17) to 6.67, marking a decrease of 1.93.
- For PBT Margin (%), as of Mar 18, the value is 0.86. This value is below the healthy minimum of 10. It has decreased from 4.08 (Mar 17) to 0.86, marking a decrease of 3.22.
- For Net Profit Margin (%), as of Mar 18, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 3.39 (Mar 17) to 0.11, marking a decrease of 3.28.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is 0.79. This value is below the healthy minimum of 8. It has decreased from 3.77 (Mar 17) to 0.79, marking a decrease of 2.98.
- For Return on Networth / Equity (%), as of Mar 18, the value is 1.64. This value is below the healthy minimum of 15. It has decreased from 8.28 (Mar 17) to 1.64, marking a decrease of 6.64.
- For Return on Capital Employeed (%), as of Mar 18, the value is 9.11. This value is below the healthy minimum of 10. It has decreased from 11.54 (Mar 17) to 9.11, marking a decrease of 2.43.
- For Return On Assets (%), as of Mar 18, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 2.98 (Mar 17) to 0.60, marking a decrease of 2.38.
- For Long Term Debt / Equity (X), as of Mar 18, the value is 0.25. This value is within the healthy range. It has decreased from 0.37 (Mar 17) to 0.25, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 18, the value is 0.73. This value is within the healthy range. It has decreased from 0.78 (Mar 17) to 0.73, marking a decrease of 0.05.
- For Asset Turnover Ratio (%), as of Mar 18, the value is 0.73. It has decreased from 0.82 (Mar 17) to 0.73, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 18, the value is 1.07. This value is below the healthy minimum of 1.5. It has decreased from 1.14 (Mar 17) to 1.07, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 18, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 17) to 0.29, marking an increase of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 18, the value is 1.47. This value is below the healthy minimum of 4. It has decreased from 1.92 (Mar 17) to 1.47, marking a decrease of 0.45.
- For Dividend Payout Ratio (NP) (%), as of Mar 18, the value is 217.73. This value exceeds the healthy maximum of 50. It has increased from 0.00 (Mar 17) to 217.73, marking an increase of 217.73.
- For Dividend Payout Ratio (CP) (%), as of Mar 18, the value is 30.89. This value is within the healthy range. It has increased from 0.00 (Mar 17) to 30.89, marking an increase of 30.89.
- For Earning Retention Ratio (%), as of Mar 18, the value is -117.73. This value is below the healthy minimum of 40. It has decreased from 0.00 (Mar 17) to -117.73, marking a decrease of 117.73.
- For Cash Earning Retention Ratio (%), as of Mar 18, the value is 69.11. This value is within the healthy range. It has increased from 0.00 (Mar 17) to 69.11, marking an increase of 69.11.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 5.08. This value is within the healthy range. It has decreased from 5.16 (Mar 17) to 5.08, marking a decrease of 0.08.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 2.62. This value is below the healthy minimum of 3. It has decreased from 3.09 (Mar 17) to 2.62, marking a decrease of 0.47.
- For Enterprise Value (Cr.), as of Mar 18, the value is 116.17. It has decreased from 126.76 (Mar 17) to 116.17, marking a decrease of 10.59.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 0.40. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.40.
- For EV / EBITDA (X), as of Mar 18, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 3.03 (Mar 17) to 3.52, marking an increase of 0.49.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.05.
- For Retention Ratios (%), as of Mar 18, the value is -117.73. This value is below the healthy minimum of 30. It has decreased from 0.00 (Mar 17) to -117.73, marking a decrease of 117.73.
- For Price / BV (X), as of Mar 18, the value is 0.11. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.11.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.05.
- For EarningsYield, as of Mar 18, the value is 0.13. This value is below the healthy minimum of 5. It has decreased from 0.72 (Mar 17) to 0.13, marking a decrease of 0.59.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kothari Sugars & Chemicals Ltd:
- Net Profit Margin: 0.11%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.11% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.64% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.29
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 44.93)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.73
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.11%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | Kothari Buildings, No.115, Mahatma Gandhi Salai, Chennai (Madras) Tamil Nadu 600034 | secdept@hckgroup.com http://www.hckotharigroup.com/kscl |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Nina B Kothari | Chairperson |
| Mr. Arjun B Kothari | Managing Director |
| Mr. M Silvester Goldwin | Whole Time Director |
| Mr. C V Krishnan | Independent Director |
| Mr. M R Mohan | Independent Director |
| Mr. S Sundarraman | Independent Director |
FAQ
What is the intrinsic value of Kothari Sugars & Chemicals Ltd?
Kothari Sugars & Chemicals Ltd's intrinsic value (as of 13 December 2025) is 7.07 which is 75.02% lower the current market price of 28.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 234 Cr. market cap, FY2025-2026 high/low of 49.8/26.0, reserves of ₹200 Cr, and liabilities of 419 Cr.
What is the Market Cap of Kothari Sugars & Chemicals Ltd?
The Market Cap of Kothari Sugars & Chemicals Ltd is 234 Cr..
What is the current Stock Price of Kothari Sugars & Chemicals Ltd as on 13 December 2025?
The current stock price of Kothari Sugars & Chemicals Ltd as on 13 December 2025 is 28.3.
What is the High / Low of Kothari Sugars & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kothari Sugars & Chemicals Ltd stocks is 49.8/26.0.
What is the Stock P/E of Kothari Sugars & Chemicals Ltd?
The Stock P/E of Kothari Sugars & Chemicals Ltd is .
What is the Book Value of Kothari Sugars & Chemicals Ltd?
The Book Value of Kothari Sugars & Chemicals Ltd is 34.2.
What is the Dividend Yield of Kothari Sugars & Chemicals Ltd?
The Dividend Yield of Kothari Sugars & Chemicals Ltd is 0.00 %.
What is the ROCE of Kothari Sugars & Chemicals Ltd?
The ROCE of Kothari Sugars & Chemicals Ltd is 3.22 %.
What is the ROE of Kothari Sugars & Chemicals Ltd?
The ROE of Kothari Sugars & Chemicals Ltd is 1.69 %.
What is the Face Value of Kothari Sugars & Chemicals Ltd?
The Face Value of Kothari Sugars & Chemicals Ltd is 10.0.